An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

NCT00811564 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
DRUG: latanoprost 0.005%

Sponsor

Allergan